Omnicell Inc
NASDAQ:OMCL

Watchlist Manager
Omnicell Inc Logo
Omnicell Inc
NASDAQ:OMCL
Watchlist
Price: 40.495 USD 2.23% Market Closed
Market Cap: 1.8B USD

Omnicell Inc
Investor Relations

Omnicell Inc. stands at the intersection of healthcare and technology, sculpting the landscape of medication management systems with its innovative spirit. Founded in 1992, Omnicell has evolved from a small enterprise into a leading provider of automated solutions for medication and supply dispensing, inventory management, and analytics. The company’s core offering, its automated dispensing systems, reshapes how hospitals, pharmacies, and healthcare providers manage medications. By utilizing cutting-edge technology, Omnicell improves efficiency, reduces medication errors, and cuts down on healthcare costs. These systems are embedded in the workflow of healthcare facilities, ensuring that medication management becomes seamless, thus elevating patient safety and clinical outcomes.

Revenue streams flow robustly from both product sales and associated services. Omnicell garners income by selling its advanced hardware systems, which include everything from pharmacy carousels to medication robotic systems, and supplements these sales with software solutions that offer predictive analytics and inventory optimization. Beyond the initial sale, a significant part of their business model includes recurring revenue through service contracts, software updates, and customer support. This dual approach not only ensures a steady cash flow but also strengthens customer relationships by consistently providing value over time. As the healthcare industry increasingly leans on technology for streamlined operations and cost management, Omnicell’s strategic positioning allows it to capitalize on the demand for sophisticated medication management solutions.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2025
Call Date
Oct 30, 2025
AI Summary
Q3 2025

Beat and Raise: Omnicell posted Q3 results that exceeded the upper end of guidance and raised full-year revenue, EBITDA, and EPS outlooks.

Strong Revenue Growth: Q3 revenue was $311 million, up 10% year-over-year and 7% quarter-over-quarter, driven by robust demand for point-of-care devices.

Profitability Under Tariff Pressure: Tariffs reduced Q3 profitability by about $6 million, with similar impact expected in Q4, but management expects lower tariff impact in 2026.

Recurring Revenue Focus: The company is expanding recurring revenues through service contracts and cloud-based offerings, giving better business visibility.

Innovation and Platform Adoption: Continued rollout and positive adoption of cloud-native OmniSphere and XTExtend offerings, with early customers providing positive feedback.

Share Buyback: Omnicell completed a $75 million share repurchase program, reducing share count by 5%.

Stable Hospital Market: Despite macro headwinds, Omnicell sees resilience in hospital and health system demand, with a major tech refresh cycle expected.

Guidance Raised: Full-year 2025 revenue now expected between $1.177 billion and $1.187 billion, with higher EBITDA and EPS guidance.

Key Financials
Revenue
$311 million
Product Revenue
$177 million
Service Revenue
$133 million
Earnings Per Share
$0.12
Non-GAAP Earnings Per Share
$0.51
EBITDA
$41 million
Free Cash Flow
$14 million
Cash and Cash Equivalents
$180 million
Days Sales Outstanding
74 days
Inventories
$107 million
Earnings Call Recording
Other Earnings Calls

Management

Mr. Randall A. Lipps
Founder, Executive Chairman, President & CEO
No Bio Available
Mr. Nchacha E. Etta
Executive VP & CFO
No Bio Available
Mr. Nnamdi Njoku
Executive VP & COO
No Bio Available
Mr. Brian H. Nutt
VP, Chief Accounting Officer & Corporate Controller
No Bio Available
Mr. Giri Chodavarapu
Senior VP & Chief Information Officer
No Bio Available
Ms. Kathleen Nemeth
Senior Vice President of Investor Relations
No Bio Available
Mr. Maximo Rocha
Senior VP & Chief People Officer
No Bio Available
Ms. Minoo Mortazavi
Senior Vice President of Global Operations
No Bio Available
Ms. Sara Dalmasso
Senior VP & GM of International
No Bio Available
Mr. David J. Vanella
Senior Vice President of Quality & Product Regulatory
No Bio Available

Contacts

Address
CALIFORNIA
Mountain View
590 E Middlefield Rd
Contacts
+16502516100.0
www.omnicell.com